DOCK
ASSIGNED TO EXAMINER
26/02/2026
Voltar para busca
Dado oficial do USPTO
CALSCREEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
58
Atualização mais recente
27/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
08/12/2011
Data de registro
04/06/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/12/2023
Última transação
27/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Bensheim, DE
Examinador
PARK, JENNY K
Unidade examinadora
L50
Titulares e representantes
Titulares
Immundiagnostik AG
Immundiagnostik AG
Representantes
Gabrielle S. Roth SUGHRUE MION, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalsmonoclonal antibodiesbuffersreagents for determination of calprotectin in disease testing for use in laboratory analysis; and reagents for in-vitro use in biochemistryclinical chemistry and micro biologyfor use in laboratory analysis; diagnostic preparations other than for medical and veterinary purposesdiagnostic preparations for clinical or medical laboratory use in the nature of diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for determination of calprotectin for use in detecting diseases; diagnostic reagents for in-vitro use in biochemistryclinical chemistry and micro biologyfor use in detecting diseases; and diagnostic preparations for clinical or medical laboratory use in the nature of diagnostic kits for detectingdifferentiating and monitoring chronic inflammatory diseasesinfectious diseasespolypscolon cancerintestinal and kidney disease diagnostic preparations other than for medical and veterinary purposesimmunochromatographic test kits and chemical preparations consisting of pre-mixed reactants and reagents for the detection of calprotectin in stoolurine and other excreted body fluids for use in laboratory analysis; chemicalsantibodies for use in industryspecifically in the manufacture of pharmaceuticals and chemical compositions for the preservation and extraction of proteineous analytes from stool for laboratory use
Classe 5
Biological preparations for medical and pharmaceutical purposes for the treatment of chronic inflammatory diseasesinfectious diseasespolypscolon cancerintestinal diseaseskidney disease; chemical substancesenzymes and antibodies for medical and pharmaceutical purposes for the treatment of chronic inflammatory diseasesinfectious diseasespolypscolon cancerintestinal diseaseskidney disease
Publicações
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/11/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
28/08/2024
INPC
INVALIDATION PROCESSED
28/08/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
16/08/2024
C71T
CANCELLED SECTION 71
15/12/2023
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/06/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
30/12/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/07/2020
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
19/05/2020
INPC
INVALIDATION PROCESSED
19/05/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
22/02/2020
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
22/06/2019
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
22/06/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
03/06/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/06/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
20/10/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/09/2013
FIMP
FINAL DISPOSITION PROCESSED
27/09/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/09/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/08/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2013
GPNX
NOTIFICATION PROCESSED BY IB
06/05/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/03/2013
PUBO
PUBLISHED FOR OPPOSITION
19/03/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/02/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/02/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/02/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
13/02/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2013
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/02/2013
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
14/01/2013
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
14/01/2013
CNCF
ACTION CONTINUING A FINAL - COMPLETED
14/01/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/12/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2012
ALIE
ASSIGNED TO LIE
12/12/2012
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/12/2012
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
22/11/2012
GNFR
FINAL REFUSAL E-MAILED
22/11/2012
CNFR
FINAL REFUSAL WRITTEN
22/11/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/09/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/09/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/09/2012
RFNP
REFUSAL PROCESSED BY IB
17/04/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/03/2012
RFRR
REFUSAL PROCESSED BY MPU
23/03/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/03/2012
CNRT
NON-FINAL ACTION WRITTEN
22/03/2012
DOCK
ASSIGNED TO EXAMINER
20/03/2012
MAFR
APPLICATION FILING RECEIPT MAILED
06/03/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/03/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CALSCREEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.